ADC Therapeutics (ADCT) Amortizatization of Intangibles: 2020-2024
Historic Amortizatization of Intangibles for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2024 value amounting to $28.2 million.
- ADC Therapeutics' Amortizatization of Intangibles fell 41.35% to $7.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $19.2 million, marking a year-over-year increase of 57.41%. This contributed to the annual value of $28.2 million for FY2024, which is 46.95% up from last year.
- According to the latest figures from FY2024, ADC Therapeutics' Amortizatization of Intangibles is $28.2 million, which was up 46.95% from $19.2 million recorded in FY2023.
- In the past 5 years, ADC Therapeutics' Amortizatization of Intangibles registered a high of $28.2 million during FY2024, and its lowest value of $47,000 during FY2020.
- For the 3-year period, ADC Therapeutics' Amortizatization of Intangibles averaged around $19.9 million, with its median value being $19.2 million (2023).
- Data for ADC Therapeutics' Amortizatization of Intangibles shows a peak YoY skyrocketed of 9,358.91% (in 2022) over the last 5 years.
- Yearly analysis of 5 years shows ADC Therapeutics' Amortizatization of Intangibles stood at $47,000 in 2020, then surged by 174.47% to $129,000 in 2021, then skyrocketed by 9,358.91% to $12.2 million in 2022, then soared by 57.41% to $19.2 million in 2023, then surged by 46.95% to $28.2 million in 2024.